Future Of Horizon Therapeutics’ Deerfield Offices Uncertain After $28B Amgen Acquisition Amgen, a biotechnology company, has agreed to acquire biopharma company Horizon Therapeutics for approximately $28B, putting into question the future of Horizon’s Deerfield, Illinois, campus.
The merger will be healthcare's largest of 2022, according to the Wall Street Journal, which first reported the news.Amgen is based in Thousand Oaks, California. Horizon is headquartered in Dublin, with offices in Deerfield, a new facility in Rockville, Maryland, and a presence across four continents.Once the deal is… Read the full story here. | | |